Posted by Michael Wonder on 01 Sep 2022
CADTH launches post-market drug evaluation program
1 September 2022 - CADTH is pleased to announce the launch of its new post-market drug evaluation program.
This important initiative fills a key gap in Canada’s drug safety and effectiveness landscape and is an exciting example of how CADTH is delivering on the “Innovate” pillar from its 2022-2025 Strategic Plan.
